In contrast, glioma pathogenesis-related protein 1 (GLIPR1) is down-regulated in prostate cancer, while forced GLIPR1 overexpression is pro-apoptotic in prostate cancer cells and is suggested as a prostate-cancer therapy [211]. This evidence concerns the gene GLIPR1 and Familial prostate cancer.